Exscientia Oct 30, 2025 BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fierce Biotech
Exscientia Oct 26, 2025 Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Acquisition and Partnerships | RXRX Stock News - Quiver Quantitative
Exscientia Oct 20, 2025 Recursion Pharmaceuticals (RXRX) Is Up 6.0% After New AI Partnerships and Exscientia Acquisition Has the Bull Case Changed? - Yahoo Finance
Exscientia Oct 13, 2025 Exscientia Wins Dismissal of Investor Suit Over CEO Misconduct - Bloomberg Law News
Exscientia May 28, 2025 The first test of Recursion's Exscientia move | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline